Insulins (Halozyme)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInsulins (Halozyme)
Drug Alias NameInsulin-hyaluronidase胰岛素 - HalozymeHyaluronidase-insulinRecombinant human hyaluronidase-insulin,Ultrafast InsulinAspart-PH20 +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHalozyme Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale UniversityHalozyme Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[4] 

Other Information

ATC CodeN/A
Related LinksN/A